Par Drugs And Chemicals Limited (PAR) — Strategic Asset Allocation Index
Par Drugs And Chemicals Limited (PAR) has a Strategic Asset Allocation Index of 53.9% as of September 2022. Strategic assets (PP&E of Rs354.93 Million plus long-term investments of Rs-) total Rs354.93 Million, measured against net assets of Rs658.96 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Par Drugs And Chemicals Limited Strategic Asset Allocation Index (2018–2022)
This chart shows how Par Drugs And Chemicals Limited's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of September 2022, the index stands at 53.9%, representing strategic assets of Rs354.93 Million against net assets of Rs658.96 Million INR. Explore PAR cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Par Drugs And Chemicals Limited (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Par Drugs And Chemicals Limited from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see PAR market cap overview.
| Year | SAAI | Strategic Assets (INR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 57.4% | Rs343.51 Million | Rs343.51 Million | Rs- | Rs598.77 Million | ▼ -8.6 pp |
| 2021 | 65.9% | Rs344.30 Million | Rs344.30 Million | Rs- | Rs522.15 Million | ▼ -20.6 pp |
| 2020 | 86.5% | Rs351.35 Million | Rs351.35 Million | Rs- | Rs406.15 Million | ▼ -38.3 pp |
| 2019 | 124.8% | Rs363.41 Million | Rs363.41 Million | Rs- | Rs291.17 Million | ▼ -63.8 pp |
| 2018 | 188.6% | Rs390.35 Million | Rs390.35 Million | Rs- | Rs206.99 Million | — |